1. What Is the Metabolomics Market?
The Metabolomics Market covers analytical platforms and bioinformatics enabling comprehensive small molecule metabolite measurement in biological samples to understand pathways, disease biomarker, and drug metabolism. Metabolomics encompasses NMR spectroscopy, mass spectrometry metabolomics, targeted metabolite panel, and metabolomics bioinformatics platform. Market dynamics reflect untargeted metabolomics enabling hypothesis-free biomarker discovery, clinical metabolomics achieving IVD clearance for inborn errors, and spatial metabolomics revealing tissue metabolite distribution.
2. Metabolomics Market Size & Forecast
3. Emerging Technologies
- AI metabolomics data integration combining metabolite, lipid, and amino acid panel for disease prediction are advancing. Growing adoption is driven by multi-metabolite signature clinical biomarker development requirements.
- Spatial metabolomics MALDI imaging revealing tumour metabolic spatial heterogeneity are advancing. Growing adoption in oncology research is driven by tumour metabolism drug target characterisation requirements.
- Clinical metabolomics panel predicting cardiovascular event risk from plasma lipid and amino acid signature are advancing. Growing adoption is driven by primary prevention risk stratification and statin therapy guidance.
- Microbiome metabolomics platforms characterising gut bacterial metabolite production profiles across diverse human microbiome compositions are advancing personalised probiotic intervention design for therapeutic and dietary applications. Growing pharmaceutical and nutrition research adoption is driven by microbiome therapeutics discovery and probiotic dietary intervention personalisation requirements that metabolomics profiling addresses at population scalervention research requirements.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Spatial Biology Market.
4. Key Market Opportunity
Demand is strongest in the Metabolomics Market at the pharmaceutical drug metabolism and pharmacokinetics sub-market, where metabolite profiling enables ADME characterisation during drug development. Clinical biomarker metabolomics creates a diagnostics opportunity as plasma metabolite panel achieves IVD clearance for disease risk. Nutrition and dietary intervention creates a consumer health research opportunity as metabolomics enables personalised nutrition guidance. Asia Pacific metabolomics creates geographic expansion as Chinese, Japanese, and South Korean academic and pharmaceutical metabolomics investment grows.
5. Top Companies in the Metabolomics Market
The following organisations hold leading positions in the Metabolomics Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Thermo Fisher (QExactive)
- Agilent (LC-MS Metabolomics)
- Bruker (timsTOF, rapifleX)
- Waters (Metabolomics MS)
- Metabolon (Metabolomics CRO)
- Nightingale Health (NMR)
- Chenomx (NMR Profiler)
- IDEOM (Bioinformatics)
- Human Metabolome Database (HMDB)
- Biocrates (Targeted Panel)
6. Market Segmentation
The Metabolomics Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Platform | NMR Spectroscopy LC-MS Metabolomics GC-MS Targeted Panel Spatial Metabolomics |
| By Application | Biomarker Discovery Drug Metabolism Nutritional Research Clinical Diagnostics Agriculture |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Metabolomics Market trajectory over the forecast period:
Thermo Fisher and Agilent Achieve Combined 40 Percent Metabolomics Mass Spectrometry Market Share.Thermo Fisher and Agilent metabolomics-capable mass spectrometry achieving combined 40 percent metabolomics analytical platform market share in 2024 demonstrate analytical instrument company metabolomics commercial leadership. Thermo Fisher QExactive achieving simultaneous identification of 5,000 metabolites in human plasma demonstrates the depth enabling untargeted metabolome coverage.
Bruker timsTOF Achieves Spatial Metabolomics Leadership for Tissue Metabolite Imaging.Bruker timsTOF SCP and rapifleX MALDI achieving spatial metabolomics tissue imaging market leadership in 2024 demonstrates mass spectrometry instrument company spatial metabolomics commercial leadership. Bruker rapifleX achieving 5-micrometre spatial resolution for lipid and metabolite tissue distribution demonstrates the imaging resolution enabling tumour metabolic heterogeneity analysis.
Metabolon and Nightingale Health Achieve Clinical Metabolomics Biomarker Platform Leadership.Metabolon and Nightingale Health NMR metabolomics achieving combined clinical biomarker panel deployment across 100 pharmaceutical and health system clients in 2024 demonstrate metabolomics platform at commercial clinical research scale. Nightingale achieving 250 plasma metabolite NMR quantification at population cohort throughput demonstrates the clinical biomarker scale.
For related market intelligence, see the Digital Pathology Market.
8. Segmental Analysis
By platform, the LC-MS Untargeted Metabolomics segment dominated the Metabolomics Market in 2025. Representing the largest revenue category as mass spectrometry metabolite identification drives the majority of research platform investment. The Targeted Clinical Metabolite Panel segment is the fastest-growing category, advancing as IVD-cleared metabolite biomarker panel achieves clinical laboratory adoption.
By application, Drug Metabolism and PK dominated in 2025, while Clinical Diagnostics is registering the highest metabolomics platform adoption growth rate.
9. Regional Analysis
Regional demand patterns across the Metabolomics Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Metabolomics Market in 2025, holding 41.5% of the global market. Pharmaceutical companies, academic biomedical research institutions, and clinical research organisations are deploying metabolomics platforms for biomarker discovery, drug mechanism investigation, and metabolic disease research applications. NIH metabolomics research funding and growing pharmaceutical interest in metabolic phenotyping for precision medicine and drug development are encouraging platform adoption. Strong biomedical research infrastructure, established analytical chemistry expertise, and high life sciences research investment are generating regional metabolomics demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 15.72% during the forecast period. Pharmaceutical companies, academic research institutions, and biotech organisations across Germany, the United Kingdom, the Netherlands, Sweden, and Switzerland are deploying metabolomics platforms for clinical biomarker identification, nutrition research, and metabolic disease drug development. European research funding and growing pharmaceutical investment in metabolic phenotyping approaches to drug development are encouraging metabolomics platform adoption. Rising academic metabolomics research activity and increasing clinical research application of metabolic biomarkers are generating European demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Metabolomics Market was valued at USD 4.42 Bn in 2025 and is projected to reach USD 14.16 Bn by 2034, growing at a CAGR of 13.8% over the 2026–2034 forecast period.
The Metabolomics Market is projected to grow at a CAGR of 13.8% from 2026 to 2034.
North America accounted for the largest share of the Metabolomics Market in 2025, holding 41.5% of the global market.
The leading companies in the Metabolomics Market include Thermo Fisher (QExactive), Agilent (LC-MS Metabolomics), Bruker (timsTOF, rapifleX), Waters (Metabolomics MS), Metabolon (Metabolomics CRO), Nightingale Health (NMR), Chenomx (NMR Profiler), IDEOM (Bioinformatics), Human Metabolome Database (HMDB), Biocrates (Targeted Panel).
Thermo fisher and agilent achieve combined 40 percent metabolomics mass spectrometry market share.
By platform, the LC-MS Untargeted Metabolomics segment dominated the Metabolomics Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.